Abstract
In early 2002, the FDA and Health Canada issued federal advisories that people should discontinue taking the herbal antianxiolitic kava kava, until further information regarding safety and potential for liver damage were determined. We conducted a field study 2 months following the advisories in Toronto, Canada to determine whether kava kava continued to be recommended to consumers at retail health food stores. Eight participants asked employees at all stores what was recommended for anxiety and whether the products were safe. Twenty-two of 34 stores recommended kava kava, 9 of which mentioned safety concerns. Physicians should be aware that federal advisories may not affect sales of unsafe products.
This is a preview of subscription content, log in via an institution to check access.
References
Kessler RC, Davis RB, Foster DF, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001;135:262–8.
Berger E. Berger Population Health Monitor 21. Toronto: Hay Associates (2000 Monograph).
Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61:2163–75.
Pittler MH, Ernst E. Kava extract for treating anxiety (Cochrane Review). Cochrane Database Syst Rev. 2001;4:CD003383.
FDA Consumer Advisory. Kava-Containing Dietary Supplements May Be Associated with Severe Liver Injury. Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration. March 25, 2002.
FDA Letter to Health Care Professionals. FDA Issues Consumer Advisory that Kava Products May Be Associated with Severe Liver Injury. U.S. Food and Drug Administration.. Center for Food Safety and Applied Nutrition. Office of Nutritional Products, Labeling, and Dietary Supplements. March 25, 2002.
Medicines Control Agency. Investigation of kava kava leads to ban following voluntary withdrawal. Available at: http://www.mca.gov.uk/whatsnew/pressreleases/kava211202.pdf, December 20, 2002. Accessed March 16, 2003.
Health Canada. Health Canada is advising consumers not to use any products containing kava. Advisory, January 16, 2002. Accessed March 16, 2003.
Health Canada. Health Canada issues a stop-sale order for all products containing kava. Available at: http://www.hc-sc.gc.ca/english/protection/warnings/./2002-56e.htm, August 21, 2002. Accessed March 16, 2003.
Ernst E, Pittler MH, Stevinson C, White AR, Eisenberg D. The Desktop Guide to Complementary and Alternative Medicine. Edinburgh: Mosby; 2001.
Lofland J, Lofland L. Analysing Social Settings, 3rd edn. Belmont, Calif: Wadsworth; 1995:101–13.
Mills E, Singh R, Bast L, et al. Emerging issues associated with HIV patients seeking advice from health food stores. Can J Pub Health. 2003;94:363–6.
Phillips LG, Nichols MH, King WD. Herbs and HIV: the health food industry’s answer. South Med J. 1995;88:911–3.
Ernst E, Cohen MH. Informed consent in complementary and alternative medicine. Arch Intern Med. 2001;161:2288–92.
CNN. Kava may link to liver damage. March 26, 2002. Available at: http://www.cnn.com/2002/HEALTH/diet.fitness/03/26/kava.warning.ap/. Accessed May 1, 2002.
Ernst E. Safety concerns about kava. Lancet. 2002;359:1865.
CDC. Hepatic Toxicity Possibly Associated with Kava-Containing Products—United States Germany & Switzerland, 1999–2002. MMWR Morb Mortal Wkly Rep. 2002;51:1065–7.
Walker AM. The relation between voluntary notification and material risk in dietary supplement safety. Food and Drug Administration docket 00N-1200; 2000. Available at: http://www.fda.gov/ohrms/dockets/00n1200. Accessed March 16, 2003.
FDA. Center for Food Safety & Applied Nutrition. Dietary Supplements. Available at: http://vm.cfsan.fda.gov/∼dms/supplmnt.html. Accessed March 16, 2003.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. Wilson is a Canadian Institutes of Health Research New Investigator. Mr. Mills is an Essiac Scholar.
Rights and permissions
About this article
Cite this article
Mills, E., Singh, R., Ross, C. et al. Impact of federal safety advisories on health food store advice. J GEN INTERN MED 19, 269–272 (2004). https://doi.org/10.1111/j.1525-1497.2004.21108.x
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2004.21108.x